(CIGI) Colliers International Bats - Overview

Exchange: NASDAQ • Country: Canada • Currency: USD • Type: Common Stock • ISIN: CA1946931070

Stock: Brokerage, Valuation, Facilities, Project, Investment

Total Rating 36

Risk 67

Buy Signal -1.16

Real Estate Services » Real Estate Development
Age: 31.1y

Market Cap: 6,538m
Avg Trading Vol: 18.3M USD

ATR: 3.26%
Peers RS (IBD): 25.93

EPS (Earnings per Share)

EPS CAGR: -8.09%
EPS Trend: -35.8%

Last SUE: 0.27
Qual. Beats: 0

Revenue

Rev. CAGR: 2.26%
Rev. Trend: 44.7%

Last SUE: 0.47
Qual. Beats: 0

Dividends

Dividend Yield	0.21%
Yield on Cost 5y	0.31%
Yield CAGR 5y	10.67%
Payout Consistency	64.6%
Payout Ratio	9.2%

Risk 5d forecast
Volatility	30.1%
Relative Tail Risk	-7.37%

Reward TTM
Sharpe Ratio	0.10
Alpha	-18.85

Character TTM
Beta	0.928
Beta Downside	0.964

Drawdowns 3y
Max DD	31.27%
CAGR/Max DD	0.22

Description: CIGI Colliers International Bats January 08, 2026

Colliers International Group Inc. (NASDAQ:CIGI) is a global commercial real-estate firm that delivers a full suite of services-including brokerage, capital-markets, tenant and landlord representation, and extensive outsourcing functions such as facilities management, lease administration, valuation, and project-management-to corporate and institutional clients across North America, Europe, Asia-Pacific and other markets.

Key metrics that shape Colliers’ outlook include: (1) FY 2023 revenue of approximately US$2.3 billion, reflecting a 9 % year-over-year increase driven by higher demand for advisory and outsourcing services; (2) the U.S. commercial-real-estate (CRE) vacancy rate, which has risen to about 12 % in Q4 2023, pressuring rental growth but also creating acquisition opportunities; and (3) the broader macro-environment, where elevated interest rates and tighter credit conditions are slowing new-construction pipelines, thereby boosting demand for Colliers’ lease-administration and property-valuation offerings.

For a deeper, data-driven view of Colliers’ valuation dynamics, you might explore the analytics platform ValueRay to see how these drivers are reflected in current market pricing.

Piotroski VR‑10 (Strict, 0-10) 5.5

Net Income: 117.1m TTM > 0 and > 6% of Revenue
FCF/TA: 0.03 > 0.02 and ΔFCF/TA -0.03 > 1.0
NWC/Revenue: 4.20% < 20% (prev 5.50%; Δ -1.30% < -1%)
CFO/TA 0.04 > 3% & CFO 266.5m > Net Income 117.1m
Net Debt (2.29b) to EBITDA (625.9m): 3.66 < 3
Current Ratio: 1.14 > 1.5 & < 3
Outstanding Shares: last quarter (36.9m) vs 12m ago -27.34% < -2%
Gross Margin: 40.05% > 18% (prev 0.40%; Δ 3965 % > 0.5%)
Asset Turnover: 83.61% > 50% (prev 73.01%; Δ 10.60% > 0%)
Interest Coverage Ratio: 4.42 > 6 (EBITDA TTM 625.9m / Interest Expense TTM 83.9m)

Altman Z'' 0.86

A: 0.03 (Total Current Assets 1.87b - Total Current Liabilities 1.64b) / Total Assets 6.81b
B: -0.02 (Retained Earnings -151.9m / Total Assets 6.81b)
C: 0.06 (EBIT TTM 371.2m / Avg Total Assets 6.52b)
D: 0.31 (Book Value of Equity 1.28b / Total Liabilities 4.09b)
Altman-Z'' Score: 0.86 = B

Beneish M -2.95

DSRI: 0.94 (Receivables 1.19b/1.05b, Revenue 5.45b/4.56b)
GMI: 1.00 (GM 40.05% / 39.93%)
AQI: 1.01 (AQ_t 0.63 / AQ_t-1 0.62)
SGI: 1.20 (Revenue 5.45b / 4.56b)
TATA: -0.02 (NI 117.1m - CFO 266.5m) / TA 6.81b)
Beneish M-Score: -2.95 (Cap -4..+1) = A

What is the price of CIGI shares?

As of February 07, 2026, the stock is trading at USD 139.72 with a total of 484,943 shares traded.
Over the past week, the price has changed by +2.21%, over one month by -4.99%, over three months by -7.13% and over the past year by +2.90%.

Is CIGI a buy, sell or hold?

Colliers International Bats has received a consensus analysts rating of 3.91. Therefore, it is recommended to buy CIGI.

StrongBuy: 2
Buy: 6
Hold: 3
Sell: 0
StrongSell: 0

What are the forecasts/targets for the CIGI price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	183.1	31.1%
Analysts Target Price	183.1	31.1%
ValueRay Target Price	135.3	-3.2%

CIGI Fundamental Data Overview February 05, 2026

P/E Trailing = 55.5584
P/E Forward = 16.9779
P/S = 1.1988
P/B = 4.5292
P/EG = 1.14
Revenue TTM = 5.45b USD
EBIT TTM = 371.2m USD
EBITDA TTM = 625.9m USD
Long Term Debt = 1.83b USD (from longTermDebt, last quarter)
Short Term Debt = 286.7m USD (from shortTermDebt, last quarter)
Debt = 2.50b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.29b USD (from netDebt column, last quarter)
Enterprise Value = 8.83b USD (6.54b + Debt 2.50b - CCE 212.5m)
Interest Coverage Ratio = 4.42 (Ebit TTM 371.2m / Interest Expense TTM 83.9m)
EV/FCF = 44.25x (Enterprise Value 8.83b / FCF TTM 199.5m)
FCF Yield = 2.26% (FCF TTM 199.5m / Enterprise Value 8.83b)
FCF Margin = 3.66% (FCF TTM 199.5m / Revenue TTM 5.45b)
Net Margin = 2.15% (Net Income TTM 117.1m / Revenue TTM 5.45b)
Gross Margin = 40.05% ((Revenue TTM 5.45b - Cost of Revenue TTM 3.27b) / Revenue TTM)
Gross Margin QoQ = 39.28% (prev 40.78%)
Tobins Q-Ratio = 1.30 (Enterprise Value 8.83b / Total Assets 6.81b)
Interest Expense / Debt = 0.91% (Interest Expense 22.7m / Debt 2.50b)
Taxrate = 22.69% (19.1m / 84.3m)
NOPAT = 287.0m (EBIT 371.2m * (1 - 22.69%))
Current Ratio = 1.14 (Total Current Assets 1.87b / Total Current Liabilities 1.64b)
Debt / Equity = 1.74 (Debt 2.50b / totalStockholderEquity, last quarter 1.44b)
Debt / EBITDA = 3.66 (Net Debt 2.29b / EBITDA 625.9m)
Debt / FCF = 11.48 (Net Debt 2.29b / FCF TTM 199.5m)
Total Stockholder Equity = 1.37b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.80% (Net Income 117.1m / Total Assets 6.81b)
RoE = 8.53% (Net Income TTM 117.1m / Total Stockholder Equity 1.37b)
RoCE = 11.58% (EBIT 371.2m / Capital Employed (Equity 1.37b + L.T.Debt 1.83b))
RoIC = 9.05% (NOPAT 287.0m / Invested Capital 3.17b)
WACC = 6.94% (E(6.54b)/V(9.04b) * Re(9.33%) + D(2.50b)/V(9.04b) * Rd(0.91%) * (1-Tc(0.23)))
Discount Rate = 9.33% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -11.93%
[DCF Debug] Terminal Value 75.38% ; FCFF base≈193.6m ; Y1≈127.4m ; Y5≈58.5m
Fair Price DCF = N/A (negative equity: EV 1.41b - Net Debt 2.29b = -879.1m; debt exceeds intrinsic value)
[DCF Warning] FCF declining rapidly (-39.81%), DCF may be unreliable
EPS Correlation: -35.82 | EPS CAGR: -8.09% | SUE: 0.27 | # QB: 0
Revenue Correlation: 44.69 | Revenue CAGR: 2.26% | SUE: 0.47 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.00 | Chg30d=-0.061 | Revisions Net=-2 | Analysts=6
EPS next Year (2026-12-31): EPS=7.56 | Chg30d=+0.041 | Revisions Net=-3 | Growth EPS=+13.2% | Growth Revenue=+7.8%

Additional Sources for CIGI Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Fund Manager Positions: Dataroma | Stockcircle